Biodesix Inc financial data

Symbol
BDSX on Nasdaq
Industry
Services-Medical Laboratories
Location
919 West Dillon Road, Louisville, CO
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 178 % +32.3%
Debt-to-equity 541 % -71.9%
Return On Equity -277 % +81.7%
Return On Assets -43.3 % +42.2%
Operating Margin -53 % +51.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 145M shares +60.8%
Common Stock, Shares, Outstanding 145M shares +64.7%
Entity Public Float 36.6M USD +7.33%
Common Stock, Value, Issued 145K USD +64.8%
Weighted Average Number of Shares Outstanding, Basic 146M shares +83.5%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +83.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 65.6M USD +48.9%
Research and Development Expense 9.03M USD -22.5%
Operating Income (Loss) -34.7M USD +28.2%
Nonoperating Income (Expense) -1.67M USD +55.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -43.8M USD +30.8%
Earnings Per Share, Basic -0.38 USD/shares +55.8%
Earnings Per Share, Diluted -0.38 USD/shares +55.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.4M USD +58.3%
Accounts Receivable, after Allowance for Credit Loss, Current 8.04M USD +39.1%
Other Assets, Current 4.58M USD +40%
Assets, Current 44M USD +52.4%
Property, Plant and Equipment, Net 28.7M USD +12.9%
Operating Lease, Right-of-Use Asset 1.92M USD -8.36%
Intangible Assets, Net (Excluding Goodwill) 6.44M USD -23.5%
Goodwill 15M USD 0%
Other Assets, Noncurrent 6.66M USD -4.44%
Assets 103M USD +18.4%
Accounts Payable, Current 2.54M USD -12.6%
Employee-related Liabilities, Current 4.96M USD +51.9%
Accrued Liabilities, Current 8.55M USD +23.1%
Contract with Customer, Liability, Current 676K USD +2.58%
Liabilities, Current 13M USD -60.3%
Contract with Customer, Liability, Noncurrent 400K USD
Operating Lease, Liability, Noncurrent 25.2M USD +2.25%
Other Liabilities, Noncurrent 620K USD -23.9%
Liabilities 74.9M USD -15.1%
Retained Earnings (Accumulated Deficit) -454M USD -10.7%
Stockholders' Equity Attributable to Parent 27.9M USD
Liabilities and Equity 103M USD +18.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.3M USD -99.2%
Net Cash Provided by (Used in) Financing Activities 791K USD
Net Cash Provided by (Used in) Investing Activities -273K USD +96.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 145M shares +64.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD +17%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31.5M USD +58%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.48M USD +42.9%
Deferred Tax Assets, Valuation Allowance 93M USD +12.7%
Deferred Tax Assets, Gross 95M USD +12.7%
Operating Lease, Liability 25.8M USD +0.26%
Depreciation 1M USD +233%
Payments to Acquire Property, Plant, and Equipment 234K USD -97%
Lessee, Operating Lease, Liability, to be Paid 45.1M USD -6%
Property, Plant and Equipment, Gross 36.9M USD +11%
Operating Lease, Liability, Current 624K USD -43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.17M USD +3.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.91M USD +62.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.3M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.06M USD -1.96%
Deferred Tax Assets, Operating Loss Carryforwards 72.7M USD +2.68%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.04M USD +8.93%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.15M USD +2.17%
Additional Paid in Capital 482M USD +17.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 483K USD -75.5%
Deferred Tax Assets, Net of Valuation Allowance 2M USD +12.8%
Share-based Payment Arrangement, Expense 6.45M USD +1.34%
Interest Expense 9.18M USD -11.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%